Published in Int Clin Psychopharmacol on May 01, 1999
Parasomnias: an updated review. Neurotherapeutics (2012) 0.98
Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies. Nat Sci Sleep (2016) 0.75
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology (2008) 3.62
Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology (1992) 3.08
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia (2007) 3.07
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology (2002) 2.44
[Placebo effect in the drug therapy of depression]. Ugeskr Laeger (2000) 2.43
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry (2008) 2.22
Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology (2007) 2.15
The effects of pramipexole in REM sleep behavior disorder. Neurology (2003) 2.10
Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology (2001) 1.95
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology (2007) 1.95
Hyperspectral imaging: a novel approach for microscopic analysis. Cytometry (2001) 1.74
Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep (2000) 1.66
Team approach to long-term intravenous feeding in patients with gastrointestinal disorders. Lancet (1978) 1.65
EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology (1999) 1.62
Development of sleep patterns in early adolescence. J Sleep Res (2001) 1.61
Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol (1993) 1.59
Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol (1991) 1.57
Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology (2001) 1.54
Phylogenetic analysis and in situ identification of the intestinal microbial community of rainbow trout (Oncorhynchus mykiss, Walbaum). J Appl Microbiol (2004) 1.50
Slow-wave activity in sleep apnea patients before and after continuous positive airway pressure treatment: contribution to daytime sleepiness. Chest (2001) 1.49
Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology (1987) 1.45
The effects of L-dopa on excessive daytime sleepiness in narcolepsy. Neurology (1991) 1.41
Nocturnal asthma: features of attacks, sleep and breathing patterns. Am Rev Respir Dis (1982) 1.41
Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J (1967) 1.40
The effect of hypnotically induced emotional states on brain potentials evoked by painful argon laser stimulation. Clin J Pain (1991) 1.39
Age-related modifications of NREM sleep EEG: from childhood to middle age. J Sleep Res (2001) 1.37
Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep (2000) 1.37
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology (2008) 1.35
Sleep spindle characteristics in healthy subjects of different age groups. Clin Neurophysiol (2001) 1.34
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet (2001) 1.30
Development of parasomnias from childhood to early adolescence. Pediatrics (2000) 1.29
Neurobiology of sleep disturbances in neurodegenerative disorders. Curr Pharm Des (2008) 1.24
Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology (2002) 1.20
Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology (1985) 1.17
Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J Infect Dis (1992) 1.09
Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry (2010) 1.08
Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep (1997) 1.04
Photodegradation of nitro-PAHs in viscous organic media used as models of organic aerosols. Environ Sci Technol (2001) 1.04
Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms. Sleep (1995) 1.04
Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol (1986) 1.03
Periodic arm movements in patients with the restless legs syndrome. Eur Neurol (2000) 1.03
Topographical distribution of spindles and K-complexes in normal subjects. Sleep (1997) 1.01
Arm restlessness in patients with restless legs syndrome. Mov Disord (2000) 1.01
The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep (1990) 1.01
The effect of local cooling upon spontaneous and evoked electrical activity of cerebral cortex. Can J Physiol Pharmacol (1970) 1.00
Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology (2004) 1.00
The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett (1988) 1.00
Nocturnal hypoxemia as a determinant of vigilance impairment in sleep apnea syndrome. Chest (1991) 0.99
Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology (1988) 0.98
Development of disturbing dreams during adolescence and their relation to anxiety symptoms. Sleep (2000) 0.98
Effects of obstructive sleep apnea on cognitive function: a comparison between younger and older OSAS patients. Sleep Med (2007) 0.97
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology (2006) 0.97
Toxic psychosis due to antiparkinsonian drugs. Can Psychiatr Assoc J (1967) 0.96
Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest (2001) 0.95
HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. Sleep (1986) 0.95
Age difference in heart rate changes associated with micro-arousals in humans. Clin Neurophysiol (2002) 0.95
Pruritus and xerosis in patients with chronic renal failure. Dan Med Bull (1980) 0.95
Altered states of consciousness in disorders of daytime sleepiness. J Neurol Sci (1975) 0.94
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry (1998) 0.94
A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads. Diabetologia (2009) 0.93
Differential DNA replication origin activities in human normal skin fibroblast and HeLa cell lines. J Mol Biol (1997) 0.93
Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects. Eur J Clin Pharmacol (1996) 0.92
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly. Clin Pharmacol Ther (1997) 0.92
Demonstration of in vitro synthesis of human papilloma viral proteins from hand and foot warts. J Invest Dermatol (1989) 0.92
Organolead compounds: environmental health aspects. Residue Rev (1979) 0.92
Predicting Parkinson's disease - why, when, and how? Parkinsonism Relat Disord (2009) 0.92
Adaptive temporal resolution optimization in helical cardiac cone beam CT reconstruction. Med Phys (2003) 0.91
Changes in the activity of respiratory neurons during sleep. Brain Res (1974) 0.91
Interhemispheric EEG coherence before and after partial callosotomy. Clin Electroencephalogr (1990) 0.91
Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category? Eur Neurol (1998) 0.90
Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon. Acta Derm Venereol (1983) 0.90
Effects of eight polycyclic aromatic compounds on the survival and reproduction of the springtail Folsomia fimetaria L. (Collembola, isotomidae). Environ Toxicol Chem (2001) 0.90
The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. Clin Neurophysiol (1999) 0.89
Age and gender effects on heart rate activation associated with periodic leg movements in patients with restless legs syndrome. Clin Neurophysiol (2003) 0.89
Familial glaucoma with sleep apnoea: a new syndrome? Thorax (1982) 0.89
Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption. Biol Psychiatry (1978) 0.89
Sleep and temporal lobe epilepsy: a case study with depth electrodes. Neurology (1981) 0.89
The fate of airborne polycyclic organic matter. Environ Health Perspect (1983) 0.88
The effect of gender on autonomic and respiratory responses during sleep among both young and middle-aged subjects. Sleep Med (2007) 0.87
Modafinil: a double-blind multicentric study. Sleep (1994) 0.87
The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci (1986) 0.87
Cultural aspects of psychotherapy. Am J Psychother (1974) 0.87
Sleep spindles in the human hippocampus: normal or epileptic activity? Sleep (1981) 0.87
Homeostatic sleep regulation in patients with idiopathic hypersomnia. Clin Neurophysiol (2000) 0.86
Canadian restless legs syndrome twin study. Neurology (2007) 0.86
The effect of COMT inhibition by tolcapone on tolerability and pharmacokinetics of different levodopa/benserazide formulations. Eur Neurol (1997) 0.86
The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy. Clin Neuropharmacol (1989) 0.85
Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology (2002) 0.85
Spectral analysis of wakefulness and REM sleep EEG in patients with sleep apnoea syndrome. Eur Respir J (1998) 0.85
Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology (2004) 0.85
Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation. Acta Obstet Gynecol Scand (1998) 0.85
Helical cardiac cone beam reconstruction using retrospective ECG gating. Phys Med Biol (2003) 0.84
Reactivity of polycyclic aromatic hydrocarbons towards nitrating species. Environ Sci Technol (1984) 0.84
Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol (1999) 0.83
The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes. Int J Obes (Lond) (2012) 0.83
Decreased interhemispheric EEG coherence during sleep in agenesis of the corpus callosum. Eur Neurol (1993) 0.83
Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol (1997) 0.83
The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulation. J Neurol (1998) 0.82